Modeling the hematogenous spread of cancer cells to distant organs poses one of the greatest challenges in the study of human metastasis. Both tumor cell-intrinsic properties as well as interactions with reactive stromal cells contribute to this process, but identification of relevant stromal signals has been hampered by the lack of models allowing characterization of the metastatic niche. Here, we describe an implantable bioengineered scaffold, amenable to in vivo imaging, ex vivo manipulation, and serial transplantation for the continuous study of human metastasis in mice. Orthotopic or systemic inoculation of tagged human cancer cells into the mouse leads to the release of circulating tumor cells into the vasculature, which seed the scaffold, initiating a metastatic tumor focus. Mouse stromal cells can be readily recovered and profiled, revealing differential expression of cytokines, such as IL1β, from tumor-bearing versus unseeded scaffolds. Finally, this platform can be used to test the effect of drugs on suppressing initiation of metastatic lesions. This generalizable model to study cancer metastasis may thus identify key stromal-derived factors with important implications for basic and translational cancer research.

Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models

Bersani F.
Co-first
;
2014-01-01

Abstract

Modeling the hematogenous spread of cancer cells to distant organs poses one of the greatest challenges in the study of human metastasis. Both tumor cell-intrinsic properties as well as interactions with reactive stromal cells contribute to this process, but identification of relevant stromal signals has been hampered by the lack of models allowing characterization of the metastatic niche. Here, we describe an implantable bioengineered scaffold, amenable to in vivo imaging, ex vivo manipulation, and serial transplantation for the continuous study of human metastasis in mice. Orthotopic or systemic inoculation of tagged human cancer cells into the mouse leads to the release of circulating tumor cells into the vasculature, which seed the scaffold, initiating a metastatic tumor focus. Mouse stromal cells can be readily recovered and profiled, revealing differential expression of cytokines, such as IL1β, from tumor-bearing versus unseeded scaffolds. Finally, this platform can be used to test the effect of drugs on suppressing initiation of metastatic lesions. This generalizable model to study cancer metastasis may thus identify key stromal-derived factors with important implications for basic and translational cancer research.
2014
74
24
7229
7238
Animals; Biomedical Engineering; Humans; Interleukin-1beta; Mice; Neoplasms; Stromal Cells; Tissue Scaffolds; Neoplasm Metastasis; Neoplasm Transplantation
Bersani F.; Lee J.; Yu M.; Morris R.; Desai R.; Ramaswamy S.; Toner M.; Haber D.A.; Parekkadan B.
File in questo prodotto:
File Dimensione Formato  
Cancer Res 2014_Bersani_main text_6000 words_final.docx

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 240.11 kB
Formato Microsoft Word XML
240.11 kB Microsoft Word XML   Visualizza/Apri   Richiedi una copia
Cancer Res 2014.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.74 MB
Formato Adobe PDF
1.74 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Cancer Res 2014_Bersani_main text_6000 words_final.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 315 kB
Formato Adobe PDF
315 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1794922
Citazioni
  • ???jsp.display-item.citation.pmc??? 31
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 50
social impact